Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer.
Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer. Cancer Lett. 2020 09 28; 488:40-49.
View in:
PubMed
subject areas
Antibiotics, Antineoplastic
Cell Line, Tumor
DNA Damage
DNA Repair
Humans
Male
Plicamycin
Prostatic Neoplasms, Castration-Resistant
Receptors, Androgen
authors with profiles
Ralf Kittler